1,25(OH)2D3 is not the only D metabolite involved in the pathogenesis of osteomalacia
- 1 September 1980
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 69 (3) , 360-368
- https://doi.org/10.1016/0002-9343(80)90005-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- NORMAL PLASMA-1,25-(OH)2-VITAMIN-D CONCENTRATIONS IN NUTRITIONAL OSTEOMALACIAThe Lancet, 1979
- Effect of 24,25-dihydroxycholecalciferol on calcium absorption in proximal small intestine in uraemia.BMJ, 1978
- Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?BMJ, 1978
- Phosphatase content of rat calvaria after in vivo administration of vitamin D3 metabolitesCalcified Tissue International, 1977
- VITAMIN D METABOLISMClinical Endocrinology, 1977
- THE ROLE OF VITAMIN D IN RENAL BONE DISEASEClinical Endocrinology, 1977
- Osteomalacia Due to 1α,25-Dihydroxycholecalciferol DeficiencyJournal of Clinical Investigation, 1977
- VITAMIN-D DEFICIENCY IN THE OSTEOMALACIA OF CHRONIC RENAL FAILUREThe Lancet, 1976
- Some characteristics of new tissue-binding proteins for metabolites of vitamin D other than 1,25-dihydroxyvitamin DBiochimica et Biophysica Acta (BBA) - General Subjects, 1976
- Tetracycline-based histological analysis of bone remodelingCalcified Tissue International, 1969